Synergistic Opioid Antagonist Delivery Systems
Legal Citation
Summary of the Inventive Concept
The present inventive concept integrates opioid antagonist delivery with cutting-edge technologies like AI, IoT, blockchain, and novel materials to create more powerful and effective systems for opioid overdose rescue, prevention, and treatment.
Background and Problem Solved
The original patent addressed the need for improved opioid antagonist delivery systems. However, these systems were limited by their inability to adapt to individual patient needs, lack of real-time monitoring, and inadequate data security. The new inventive concept solves these problems by incorporating advanced technologies to enhance personalized treatment, real-time monitoring, and secure data management.
Detailed Description of the Inventive Concept
The inventive concept encompasses various synergistic combinations of opioid antagonist delivery systems with AI, IoT, blockchain, and novel materials. For instance, Claim 1 describes a wearable device with a sensor that detects opioid exposure, triggering automatic administration of an opioid antagonist via a blockchain-based platform. Claim 2 details a method for personalized opioid antagonist delivery using an IoT-enabled injector device that communicates with a cloud-based server. Claim 3 presents a composition that releases the antagonist in response to an electrical signal generated by a wearable device, triggered by a machine learning algorithm. These systems enable real-time monitoring, secure data storage, and personalized treatment, significantly improving opioid overdose rescue and prevention.
Novelty and Inventive Step
The new claims introduce the novel combination of opioid antagonist delivery with AI, IoT, blockchain, and novel materials, providing a significant inventive step over the original patent. The integration of these technologies enables real-time monitoring, secure data management, and personalized treatment, which are not present in the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different AI algorithms, IoT devices, or blockchain platforms. Variations could involve the integration of additional technologies, such as augmented reality or 5G networks, to further enhance the systems' capabilities.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the pharmaceutical, healthcare, and technology industries. The systems could be marketed to hospitals, clinics, and emergency responders, as well as to individuals at risk of opioid overdose. The market size is substantial, with the global opioid antagonist market projected to reach $1.5 billion by 2025.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical delivery systems, medical device technologies, and opioid antagonist formulations with a focus on advanced drug delivery mechanisms and patient monitoring
Person of Ordinary Skill (PHOSITA) Profile
A professional with expertise in pharmaceutical engineering, medical device design, and biotechnology, possessing advanced knowledge of drug delivery systems, sensor technologies, and medical informatics
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies with existing opioid antagonist delivery systems represents a predictable evolution of pharmaceutical innovation. The source patent's focus on precise nalmefene delivery naturally suggests opportunities for technological enhancement through monitoring and personalized delivery mechanisms. The proposed variations leverage well-established technological domains like AI, IoT, and blockchain to extend the core pharmaceutical invention's functionality and effectiveness.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,547 |
|---|---|
| Title | Compositions and methods for opioid antagonist delivery |
| Assignee(s) | Purdue Pharma L.P. |